[eHi Files Amended Transaction Statement Shanghai, China, July 3, 2018 Tel: +86 (21) 6468-7000 ext. 8830 E-Mail: ir@ehic.com.cn As of the date of this release, Crawford’s purchase of the IGC Offered Securities and the GS Offered Shares has not been consummated, nor has any definitive sale and purchas]
[Number 1 Corporate Social Responsibility Report 2017, released on June 28, 2018. build-out the Companys ability to effectively sustain its growth and to achieve or enhance profitability; changes in the PRC telecommunications industry resulting from the issuance of licenses for telecommunicati]
[PRELIMINARY PROXY STATEMENT OF THE COMPANY , 2018 Shareholders of eHi Car Services Limited Re: Notice of Extraordinary General Meeting of Shareholders Dear Shareholder: You are cordially invited to attend an extraordinary general meeting of shareholders of eHi Car Services Limited, an exempted compa]
[Sinovac Raises $86.73 Million Through Private Placement Transaction · Vivo Capital and Advantech Capital Each Hold an Approximately 8.3% Stake in Sinovac After the Private Placement Transaction · Proceeds Will Be Used to Fund Improvement and Construction of Facilities for R&D Relating to Quality Con]
[Sinovac Raises $86.73 Million Through Private Placement Transaction · Vivo Capital and Advantech Capital Each Hold an Approximately 8.3% Stake in Sinovac After the Private Placement Transaction · Proceeds Will Be Used to Fund Improvement and Construction of Facilities for R&D Relating to Quality Con]
[SHARE PURCHASE AGREEMENT 股份购买协议 ____ "Seller" _____ "Purchaser" This Share Purchase Agreement (the "Agreement") is made as of the 4th day of June, 2018 by and between Ronghua Wang, with the People's Republic of China (the "PRC") Passport No. 2018 6 4 E85615992 (" ") K04837814 (" ") 本股份购买协议（"本协议"）于 W]
[SHARE PURCHASE AGREEMENT 股份购买协议 ____ "Seller" _____ "Purchaser" This Share Purchase Agreement (the "Agreement") is made as of the 4th day of June, 2018 by and between Ronghua Wang, with the People's Republic of China (the "PRC") Passport No. 2018 6 4 E85615992 (" ") K04837814 (" ") 本股份购买协议（"本协议"）于 W]
[UNAUDITED PRO FORMA CONDENSED FINANCIAL INFORMATION The following unaudited pro forma condensed combined financial statements (the Pro Forma Financial Statements) give effect to the Acquisition as well as the related financing transaction, which include the proposed issuance of US$650 million Conv]
[FOR RELEASE July 2, 2018 China Biologic Announces Results of Its 2018 Annual General Meeting of Shareholders BEIJING, China — July 2, 2018 — At the Annual Meeting, shareholders of the Company approved the re-election of each of Mr. Yungang Lu and Mr. Zhijun Tong as a Class III director to serve on t]
